NCT07414095 Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
| NCT ID | NCT07414095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Izmir Bakircay University |
| Condition | End-Stage Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-12-15 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate frailty, nutrition, sarcopenia, and psychological health in people waiting for a liver transplant. The purpose is to understand how these factors affect outcomes before and after transplantation. By identifying patients at higher risk early, the study aims to support the development of better care programs in the future. Participants will complete simple tests of physical strength, walking speed, and daily activity levels. Their nutrition and psychological well-being will also be assessed. The study will then look at how these results relate to medical scores used in liver disease and to outcomes after transplant, such as hospital stay, complications, or survival. Adults aged 18-65 years who are on the liver transplant waiting list and can understand Turkish are eligible to join.
Eligibility Criteria
Inclusion Criteria: * Being listed as a liver transplant candidate * Age between 18 and 65 years * Ability to understand the Turkish language Exclusion Criteria: * Presence of orthopedic and/or neurological problems severe enough to prevent completion of assessment tools * Inability to understand verbal commands * Being a recipient of multiple organ transplants * Presence of serious active extrahepatic malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07414095 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying End-Stage Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07414095 currently recruiting?
Yes, NCT07414095 is actively recruiting participants. Contact the research team at ayse.vatansever@bakircay.edu.tr for enrollment information.
Where is the NCT07414095 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07414095 clinical trial?
NCT07414095 is sponsored by Izmir Bakircay University. The trial plans to enroll 60 participants.